Literature DB >> 34239602

Speculating on Precarious Income: Finance Cultures and the Risky Strategies of Healthy Volunteers in Clinical Drug Trials.

Jill A Fisher1, Megan M Wood2, Torin Monahan2.   

Abstract

Speculation has become a normalized occupational strategy and quotidian economic rationality that extends throughout society. Although there are many contemporary articulations of speculation, this article focuses on contract labor as a domain of financialization. Seen through this lens, contract labor can be understood as a speculative investment strategy wherein individuals leverage whatever assets they have at their disposal-savings, time, bodily health-to capture economic advantages. In particular, we explore the speculative practices of healthy individuals who enroll in pharmaceutical drug trials as their primary or critical source of income. Mobilizing speculative logics to maximize the money they can earn from their clinical trial participation, these contract workers employ what we term a future-income-over-immediate-pay calculus. This speculative calculus valorizes fictional projections of significant long-term future income over present financial opportunities. For the economically precarious individuals in our study, we argue that rather than effectively increasing their income, speculation on contract work serves a compensatory function, providing an important-but ultimately inadequate-sense of control over market conditions that thrive upon workers' economic insecurity.

Entities:  

Keywords:  clinical trials; finance capitalism; gig work; independent contractors; labor; precarity; speculation

Year:  2020        PMID: 34239602      PMCID: PMC8259560          DOI: 10.1080/17530350.2020.1850504

Source DB:  PubMed          Journal:  J Cult Econ        ISSN: 1753-0350


  24 in total

1.  "My Body is One of the Best Commodities": Exploring the Ethics of Commodification in Phase I Healthy Volunteer Clinical Trials.

Authors:  Rebecca L Walker; Jill A Fisher
Journal:  Kennedy Inst Ethics J       Date:  2019

2.  Sacrificial Labour: Social Inequality, Identity Work, and the Damaging Pursuit of Elusive Futures.

Authors:  Torin Monahan; Jill A Fisher
Journal:  Work Employ Soc       Date:  2019-11-08

3.  Framing effects and risk-sensitive decision making.

Authors:  Sandeep Mishra; Margaux Gregson; Martin L Lalumière
Journal:  Br J Psychol       Date:  2011-06-15

4.  'I'm still a hustler': entrepreneurial responses to precarity by participants in phase I clinical trials.

Authors:  Torin Monahan; Jill A Fisher
Journal:  Econ Soc       Date:  2016-01-06

5.  Healthy Volunteers' Perceptions of the Benefits of Their Participation in Phase I Clinical Trials.

Authors:  Jill A Fisher; Lisa McManus; Megan M Wood; Marci D Cottingham; Julianne M Kalbaugh; Torin Monahan; Rebecca L Walker
Journal:  J Empir Res Hum Res Ethics       Date:  2018-10-08       Impact factor: 1.742

6.  Phase 1 healthy volunteer willingness to participate and enrollment preferences.

Authors:  Stephanie C Chen; Ninet Sinaii; Gabriella Bedarida; Mark A Gregorio; Ezekiel Emanuel; Christine Grady
Journal:  Clin Trials       Date:  2017-08-02       Impact factor: 2.486

7.  Advancing Ethics and Policy for Healthy-Volunteer Research through a Model-Organism Framework.

Authors:  Jill A Fisher; Rebecca L Walker
Journal:  Ethics Hum Res       Date:  2019-01

8.  Performance enhancement, elite athletes and anti doping governance: comparing human guinea pigs in pharmaceutical research and professional sports.

Authors:  Silvia Camporesi; Michael J McNamee
Journal:  Philos Ethics Humanit Med       Date:  2014-02-05       Impact factor: 2.464

9.  Healthy volunteers' perceptions of risk in US Phase I clinical trials: A mixed-methods study.

Authors:  Jill A Fisher; Lisa McManus; Marci D Cottingham; Julianne M Kalbaugh; Megan M Wood; Torin Monahan; Rebecca L Walker
Journal:  PLoS Med       Date:  2018-11-20       Impact factor: 11.069

10.  Picking and Choosing Among Phase I Trials : A Qualitative Examination of How Healthy Volunteers Understand Study Risks.

Authors:  Jill A Fisher; Torin Monahan; Rebecca L Walker
Journal:  J Bioeth Inq       Date:  2019-11-12       Impact factor: 1.352

View more
  1 in total

1.  Healthy volunteers in US phase I clinical trials: Sociodemographic characteristics and participation over time.

Authors:  Corey A Kalbaugh; Julianne M Kalbaugh; Lisa McManus; Jill A Fisher
Journal:  PLoS One       Date:  2021-09-07       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.